{"nct_id":"NCT05651711","title":"A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2022-12-14","start_date_type":"ACTUAL","primary_completion_date":"2024-06-05","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}